Stoyanova Ⅱ, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis[J]. Acta Histochem, 2002, 104(2): 185-192.
[3]
Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis[J]. Lab Invest, 1993, 69(2): 238-249.
[4]
Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice[J]. Gastroenterology, 1990, 98(3): 694-702.
[5]
Butzner JD, Parmar R, Bell CJ, et al. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat[J]. Gut, 1996, 38(4): 568-573.
[6]
Dieleman L, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines[J]. Clin Exp Immunol, 1998, 114(3): 385-391.
[7]
Manktelow A, Meyer AA. Lack of correlation between decreases chemotaxis and susceptibility to infection in burned rats[J]. Trauma, 1986, 26(2): 143-148.
Wirtz S, Neurath MF. Gene transfer approaches for the treatment of inflammatory bowel disease[J]. Gene Ther, 2003, 10(10): 854-860.
[10]
Kashiwase Y, Inamura H, Morioka J, et al. Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues[J].Allergol immunopathol, 2008, 36(5): 271-276.
[11]
Raithel M, Winterkamp S, Pacurar A, et al. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease[J]. Scand J Gastroenterol, 2001, 36(2): 174-179.
[12]
Bischoff SC, Lorentz A, Schwengberg S, et al. Mast cells are an important cellular source of tumor necrosis factor alpha in human intestinal tissue[J]. Gut, 1999, 44(5): 643-652.
[13]
Kruschewski M, Buhr HJ. The vasculitis in IBD is associated with the degree of inflammation[J]. Dig Dis Sci, 2010, 55(3):733-738.
[14]
Seidelin JB, Nielsen OH. Epithelial apoptosis:cause or consequence of ulcerative colitis [J]. Scand J Gastroenterol, 2009, 44(12): 1429-1434.
[15]
Braun A, Treede I, Gotthardt D, et al. Alterations of phospholipids concentration and species composition of the intestinal mucus barrier in ulcerative colitis:a clue to pathogenesis[J]. Inflamm Bowel Dis, 2009, 15(11): 1705-1720.
[16]
Villegas I, Alarcón DC, Orjales A, et al. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulfate sodium-induced colitis in mice[J]. Int Immunopharmacol, 2003, 3(13-14): 1731-1741.
[17]
Magro F, Fraga S, Azevedo I, et al. Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitis[J]. Dig Dis Sci, 2006, 51(3): 495-501.
[18]
Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease[J]. World J Gastroenterol, 2007, 13(42): 5581-5593.
[19]
Chung HL, YUE GG, To KF, et al. Effect of scutellariae radix extract on experimental dextran-sulfate sodium-induced colitis in rats[J].World J Gastroenterol, 2007, 13(42): 5605-5611.
[20]
Damiani CR, Benetton CA, Stoffel C, et al. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium[J].J Gastroenterol Hepatol, 2007, 22(11): 1846-1851.
[21]
Arafa HM, Hemeida RA, El-bahrawy AI, et al. Prophylactic role of curcumin in dextran sulfate sodium(DSS)-induced ulcerative colitis murine model[J]. Food Che Toxicol, 2009, 47(6): 1131-1137.
[22]
Boughton-smith NK, Evans SM, Whittle BR, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn’s disease[J]. Lancet, 1993, 342(8867): 338-340.
[23]
Rachmilewitz D, Stamler JS, Karmeli F, et al. Peroxynitrite-induced rat colitis--a new model of colonic inflammation[J]. Gastroenterology, 1993, 105(6): 1681-1688.
[24]
Rumi G, Tsubouchi R, Nishio H, et al. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats[J]. J Physiol Pharmacol, 2004, 55(4): 823-836.
